An American kindred with systemic amyloidosis presenting with carpal tunnel syndrome, peripheral neuropathy, and cardiomyopathy is reported. The transthyretin gene of a patient was analysed by direct DNA sequencing and both cytosine and thymine were present at the first base of codon 24. This new point mutation in exon 2 results in the amino acid substitution of serine for proline in the A-B loop of the transthyretin molecule. DNA testing for this mutant allele by restriction fragment length polymorphism analysis based on the polymerase chain reaction is described. (J Med Genet 1995;32:279-281) 
Familial amyloid polyneuropathy (FAP) is a genetic disorder with late onset autosomal dominant inheritance. It is characterised by extracellular deposition of eosinophilic proteinaceous fibrillar substance known as amyloid.' It is a systemic disease and causes various kinds of clinical symptoms including autonomic dysfunction, sensorimotor neuropathy, carpal tunnel syndrome (CTS), vitreous opacification, cardiomyopathy, renal dysfunction, and gastrointestinal tract disorder.2 It was originally described by Andrade in 1952 as familial atypical generalised amyloidosis in a large Portuguese kindred,3 and has been reported in many countries all over the world. In 1983 the first variant transthyretin (TTR), which had an amino acid substitution of methionine for valine at position 30, was found to be responsible for the disease. 4 Since then various mutations in transthyretin have been shown to be associated with the disease.
In this study we report a kindred with systemic amyloidosis manifested as CTS, polyneuropathy, and cardiomyopathy and a new mutation in exon 2 of the TTR gene which leads to an amino acid substitution of serine for proline at position 24 of mature TTR.
Case reports
The proband (II6, fig 1) , a 67 year old white man who was born in Kentucky, presented with 18 months ofuncontrolled diarrhoea associated with a 10 kg weight loss. He had had bilateral carpal tunnel surgery 15 years earlier, was impotent since the age of 59, and had paraesthesia in both lower extremities to the mid-calf of two years' duration. There was a history of cardiac irregularity and his echocardiogram showed evidence of amyloid cardiomyopathy. He died from cardiac failure at the age of 69.
His family history is notable. Three of his five sibs (II-2, II-4, II-5) died of cardiac disease. One of them (II2) died at the age of 72 and necropsy showed advanced cardiac amyloidosis. Two of his three sons (III-5, III-6) are also reported to have amyloidosis. Another brother of the proband (II-5) was documented to have bilateral CTS at the time of his death at the age of 73. His 52 year old daughter (III-16) has bilateral CTS.
Materials and methods
Blood samples were obtained from three affected members (II-6, III*5, and III-6) and six at accepted for publication 28 
